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ABSTRACT: Sepsis is the most common cause of neonatal mortality. As per National 
Neonatal Perinatal Database (NNPD) 2002-2003, the incidence of neonatal sepsis in India 
was 30 per 1000 live birth. It is 3% among intramural babies and 39.7% among extramural 
admissions. The early manifestations of neonatal sepsis are vague and ill-defined. Novel 
approaches in the diagnosis of neonatal sepsis include heart rate analysis on ECG or 
colorimetric analysis of skin color.  Although blood culture is the gold standard for the 
diagnosis of sepsis, culture reports would be available only after 48-72 hours. In this era of 
multidrug resistance, it is mandatory to avoid unnecessary use of antibiotics to treat non-
infected infants. Thus, rapid diagnostic test(s) that differentiate infected from non-infected 
infants, particularly in the early newborn period, that include Interleukien-6 (IL-6), 
neutrophil CD64 index, procalcitonin and nucleated RBC count, have the potential to make 
a significant impact on neonatal care. The aim of this review is to specify the diagnostic 
criteria, treatment guidelines and a summary of the newer diagnostic tests of sepsis.  
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INTRODUCTION
Ψ 
 
Sepsis is the commonest cause of neonatal 
mortality and is responsible for 30-50% of total 
neonatal deaths each year in developing countries.
1-
3 It is estimated that up to 20% of neonates develop 
sepsis and approximately 1% die of sepsis related 
causes.
2 The term neonatal sepsis, refers to 
systemic infection of neonates including 
septicemia, pneumonia, meningitis, arthritis, 
osteomyelitis, and urinary tract infection. As per 
National Neonatal Perinatal Database (NNPD) 
2002-2003, the incidence of systemic infection is 
3% among intramural babies in tertiary care 
institutions in India,  with septicemia being present 
in three fourth of the cases and pneumonia in one 
third of neonates.  Infection is the primary cause of 
mortality in 18.6% of intramural neonates in which 
Klebsiella pneumoniae is the most frequent 
bacterial isolate (32.5%), followed by 
Staphylococcus aureus (13.6%).  
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Sepsis is 12 times more common in extramural 
admissions (39.7%). In extramural admissions, 
Klebsiella is the commonest bacteria responsible 
(27.5%), the next common being S. aureus 
(14.9%). Sepsis is responsible for death in 38.0% 
of these extramural babies.
3, 4 
In a north Indian tertiary care center Sundaram et al 
studied the incidence of neonatal sepsis between 
the two time periods(epoch-1-1991-1996, and 
epoch-2-2001-2006)  and   it was found that  that 
incidence of  early onset sepsis did not change 
between the epochs but the incidence of late onset 
sepsis increased from 12-16.5 per 1000 live 
births(p<0.001).
5 
 
Definition 
 
National Neonatal Forum of India has defined 
neonatal sepsis as follows:
 3 
Probable (Clinical) Sepsis: In an infant having 
clinical picture suggestive of septicemia, if there is 
the presence of any one of the following criteria: 
•  Existence of predisposing factors: maternal 
fever or foul smelling liquor or prolonged 
rupture of membranes (>24 hrs) or gastric 
polymorphs (>5 per high power field). Tripathi et al / Neonatal sepsis: past, present and future 
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•  Positive septic screen - presence of two of the 
four parameters namely, TLC (< 5000/mm), 
band to total polymorphonuclear cells ratio of 
>0.2, absolute neutrophil count < 1800/cumm, 
C-reactive protein (CRP) >1mg/dl and micro 
ESR > 10 mm-first hour. 
•  Radiological evidence of pneumonia. 
Culture Positive Sepsis: In an infant having clinical 
picture suggestive of septicemia, pneumonia or 
meningitis, if there is presence of either of the 
following: 
•  Isolation of pathogens from blood or CSF or 
urine or abscess (es) 
•  Pathological evidence of sepsis on autopsy. 
 
Classification 
 
Neonatal sepsis is of two types: 
Early onset Sepsis (EOS: Early onset sepsis 
presents within first 72 hours of life. In severe 
cases the neonate may be symptomatic in utero 
(fetal tachycardia, poor beat to beat variability). 
Clinically, the neonate usually presents as 
respiratory distress and pneumonia. Presence of the 
following risk factors has been associated with an 
increased risk of EOS:
 6, 7 
•  Low birth weight (<2500gms) or preterm baby  
•  Febrile illness in the mother with in 2 weeks 
prior to delivery  
•  Foul smelling and/or meconium stained liquor 
amnii. 
•  Prolonged rupture of membrane (>24 hours). 
•  More than 3 vaginal examinations during 
labor. 
•  Prolonged and difficult delivery with 
instrumentation. 
•  Perinatal asphyxia (Apgar score <4 at 1 minute 
of age) or difficult resuscitation.     
Neonates with presence of foul smelling liquor or 
three of above mentioned risk factors should be 
considered to have EOS & treated with antibiotics. 
Presence of ≥2 risk factors should be investigated 
with sepsis screen and treated accordingly.
8 
Late onset Sepsis (LOS): Late onset sepsis usually 
presents after 72 hours of age. The source of 
infection is either nosocomial or community 
acquired and neonates usually present with 
septicemia, pneumonia or meningitis.
9,10 Risk 
factors for development of LOS include:  
•  NICU admission 
•  Poor hygiene 
•  Low birth weight (LBW) 
•  Poor cord care 
•  Prematurity 
•  Bottle feeding 
•  Invasive procedure 
•  Superficial infection (pyoderma, umbilical 
sepsis) 
•  Prelacteal feeding 
•  Ventilation 
•  Aspiration of feeds 
 
CLINICAL FEATURES 
  
Manifestations of neonatal sepsis are vague and ill-
defined. Alteration in established feeding behavior 
is common and early, but is a nonspecific 
symptom. Other features are hypothermia or fever 
(former is more common in LBW babies), lethargy, 
poor cry, poor perfusion i.e. prolonged capillary 
refill time (>2 seconds), hypotonic or absent 
neonatal reflexes, bradycardia or tachycardia, 
respiratory distress i.e. apnea or gasping 
respiration, hypoglycemia or hyperglycemia and 
metabolic acidosis. System wise specific features 
are: 
Central nervous system: These are bulging anterior 
fontanel, blank look, high-pitched cry, excessive 
irritability, coma, seizures, and neck retraction. 
Presence of these signs should raise clinical 
suspicion of meningitis 
Cardiac: The cardiac signs are mainly hypotension 
and poor perfusion. A recent study emphasized the 
value of early diagnosis of sepsis using analysis of 
heart rate characteristics on ECG monitoring. 
Griffin et al found that abnormal heart rate 
characteristics such as reduced variability and 
transient decelerations occurred 24 hours prior to 
onset of symptoms in sepsis and sepsis like 
illness.
11 Another group found that sample 
asymmetry of RR interval increased in the 3-4 days 
preceding sepsis with the steepest increase in the 
last 24 hours. These tests may prove
  helpful in 
starting the therapy long before the baby shows 
signs of deterioration.
12  
Gastrointestinal: These are feed intolerance, 
vomiting, diarrhea, abdominal distension, paralytic 
ileus, and necrotising enterocolitis. 
Hepatic:  The common hepatic signs are 
hepatomegaly and direct hyperbilirubinemia 
(Infants with the onset of jaundice after 8 days of 
age or with direct hyperbilirubinemia were more 
likely to have urinary tract infection.)
13 
Renal:  There may be acute renal failure. 
Hematological: Hematological signs are bleeding 
and petechiae, purpura. 
Skin: There may be multiple pustules, sclerema, 
mottling, umbilical redness and discharge. De 
Felice et al used Colorimetric analysis of skin color 
for severity of sepsis. Color readings were taken 
from 10 different body sites using a portable 
tristimulus and color was expressed using the 
standard CIE *a*b* system. Skin CIE b*   values 
were significantly lower in severely ill group. A 
low b* value on abdomen had 92.6% sensitivity 
and 96.6% specificity for severe illness.
14  
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INVESTIGATIONS 
 
Blood culture  
 
Blood culture is the gold standard for diagnosis of 
septicemia. It should be done in all cases before 
starting antibiotics. One-mL sample of blood 
should be adequate for a blood culture bottle 
containing 5-10 mL of culture media.  Blood 
culture should be observed for 72 hours before 
labelling it sterile. It is now possible to detect 
growth in 12-24 hours by BACTEC or 
BACT/ALERT culture system which can detect 
bacteria at a concentration of 1-2 cfu per ml. Blood 
samples collected from indwelling catheters or 
lines are likely to be contaminated. 
 
Sepsis screen
15,16 
 
This is a panel of tests consisting of: 
Component  Abnormal value 
TLC <  5000/mm3 
ANC  < as per Manroe chart for term
11 
and Mouzinho’s chart for very 
LBL (VLBW) infants
12 
Immature/ 
total 
neutrophil 
> 0.2 
Micro-ESR  > 15mm in 1st hr 
CRP >  1mg/dl 
All neonates suspected to have sepsis should have a 
septic screen to corroborate the diagnosis. 
However, the decision to start antibiotics need not 
be conditional to the sepsis screen result, if there is 
a strong clinical suspicion of sepsis. Sepsis screen 
is considered positive if two of these are positive. If 
the screen is negative but clinical suspicion 
persists, it should be repeated within 12 hours. If 
the screen is still negative, sepsis can be excluded 
with reasonable certainty. The absolute neutrophil 
count varies considerably in the immediate 
neonatal period and normal reference ranges are 
available from Manroe’s chart.
17 For very low birth 
weight infants, the reference ranges are available 
from Mouzinho’s charts.
18  Presence of two 
abnormal parameters in screen is associated with 
sensitivity 93-100%, specificity 83%, positive and 
negative predictive value of 27% and 100%, 
respectively in detecting sepsis.  Rosenberg et al 
validated the only existing
 feasible score introduced 
by Singh et al. in 2003 and to create
 an improved 
score. In their 
 five-sign model requiring at least 
one clinical sign of infection
 (apnea, hepatomegaly, 
jaundice, lethargy and pallor) had an
 area under the 
receiver operating characteristic of 0.70, sensitivity
 
of 77.1%, and PPV of 64.9.
19  
In a recently published paper, the authors have 
evaluated the SNAP II score for the assessment of 
their illness severity which consists of 6 
physiological parameters, namely lowest mean 
arterial pressure (MAP), worst ratio of partial 
pressure of oxygen (PaO2) to fraction of inspired 
oxygen (FiO2), lowest temperature (in ºF), lowest 
serum pH, occurrence of multiple seizures, and 
urine output (<1mL/kg/hr). They found that SNAP 
II can predict mortality as well as organ 
dysfunction in severely septic neonates; individual 
components of the score do not have equal 
predictive ability.
20 
 
Lumbar puncture (LP) 
 
The incidence of meningitis in neonatal sepsis has 
varied from 0.3-3% in various studies
3,9.  In EOS, 
lumbar puncture is indicated in the presence of a 
positive blood culture or if the clinical picture is 
consistent with septicemia. In situations of late 
onset sepsis, LP should be done in all infants prior 
to starting antibiotics. LP should not be done in 
following cases:
21 
•  Asymptomatic babies being investigated for 
maternal risk factors. However, LP should be 
preformed in these cases as well if blood 
culture becomes positive subsequently. 
•  Premature neonates presenting with respiratory 
distress syndrome.  
It should be postponed in critically ill and 
haemodynamically unstable baby; if traumatic it 
should be repeated with in 12-72 hours.  The 
cerebrospinal fluid characteristics are unique in the 
newborn period and normal values are given in 
Table 1
21. 
 
Table 1: Normal values of CSF in newborn 
period 
 
Tests Term  Preterm 
Cells    
WBCs  7 (0-32)  9 (0-29) 
Polymorphonuclear 
cells 
61 %  57 % 
Protein (mg /dl)  90 (20-170)  115 (65-150) 
Glucose (mg / dl)  52 (34-119)  50 (24-63) 
CSF glucose : 
blood glucose 
81 (44-248)  74 (55-105) 
 
Urine culture 
 
The rate of positive urine culture in infants with 
early onset sepsis is low. Given the low yield of 
positive urine culture results and costs of 
processing the specimens, urine culture should not 
be part of traditional sepsis evaluation in first 72 
hours of life.
22 Urine cultures obtained by 
suprapubic puncture or bladder catheterization have 
been recommended in all cases of LOS. However, 
neonates at risk for fungal sepsis and very low birth 
weight infants with poor weight gain should have a Tripathi et al / Neonatal sepsis: past, present and future 
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urine examination done to exclude urinary tract 
infection (UTI). UTI may be diagnosed in the 
presence of one of the following: (a) >10 WBC/mm 
in a 10 mL centrifuged sample (b) >10 organisms 
/mL in urine obtained by catheterization and (c) 
any organism in urine obtained by suprapubic 
aspiration. 
 
Radiology 
 
Chest X-Ray is done in cases of respiratory distress 
or apnea. Abdominal X-ray should be done for 
diagnosis of necrotizing enterocolitis. 
 
NEWER DIAGNOSTIC TESTS FOR 
DIAGNOSIS OF NEONATAL SEPSIS 
 
Isolation of bacteria from blood is a standard and 
most specific method used to diagnose neonatal 
sepsis.  Positive cultures ranged from 8% to 73% in 
the diagnosis of potential neonatal sepsis.
23 An 
additional drawback of culture based diagnosis is 
the 24–48 hour assay time. Newer diagnostic tests 
can be grouped into: 
1.  Acute phase reactants 
2.  Cell surface markers 
3.  Granulocyte colony stimulating factor 
4.  Cytokines  
5.  Molecular genetics 
6.  Mol cell proteomics 
 
Acute phase reactants 
 
These groups of endogenous peptides are produced 
by the liver as part of an immediate response to 
infection or tissue injury. These reactants are C-
reactive protein, procalcitonin, fibronectin, 
haptoglobin, lactoferrin, neopterin and 
oromucosoid 
C-reactive protein: CRP is synthesized within six 
to eight hours of exposure to an infective process or 
tissue damage, with a half life of 19 hours, and can 
increase more than 1000-fold during an acute phase 
response.   In a study it was concluded that CRP, 
IL-6 and IgM are helpful in the early diagnosis of 
Gram-negative neonatal sepsis and CRP continues 
to be the best single test.  A CRP value of 5 mg/l 
was the best among the three parameters with 95% 
sensitivity and 98% negative predictive value. The 
best combination was CRP > or = 5 mg/l and/or 
IgM of > or =20 mg/dl. The use of both CRP and 
IgM in combination was the most helpful in 
predicting Gram-negative neonatal sepsis which 
has a significant role in making decisions regarding 
antibiotics treatment.
24 
Another recent study was done to compare the 
efficiency of Serum Amyloid A (SAA) with that of 
C-reactive protein (CRP) and procalcitonin (PCT) 
in diagnosis and follow-up of neonatal sepsis in 
preterm infants showed that SAA is an accurate and 
reliable marker for diagnosis and follow-up of 
neonatal sepsis. It is especially useful at the onset 
of inflammation for rapid diagnosis of neonatal 
sepsis and can be safely and accurately used in 
combination with other sepsis markers such as CRP 
and PCT in diagnosis and follow-up of neonatal 
sepsis in preterm infants.
25 
Procalcitonin: Procalcitonin (PCT) is  produced by 
monocytes and hepatocytes which begins to rise 
four hours after exposure to bacterial endotoxin, 
peaking at six to eight hours, and remaining raised 
for at least 24 hours with a half life of 25–30 hours. 
Several studies have shown that serum 
procalcitonin concentrations increase appreciably 
in systemic bacterial infection. In a study done by 
Cetinkaya M et al median procalcitonin levels were 
higher in the septic group compared with the non-
septic group at the time of the sepsis workup (2.7 
vs 0.5 ng/ml, p=0.003), at 1-24 h after the sepsis 
workup (4.6 vs 0.6 ng/ml, p=0.003), and at 25-48 h 
(6.9 vs 2.0 ng/ml, p=0.016). Using high cut-off 
levels, both procalcitonin (2.3 ng/ml) and CRP (30 
mg/l) had high specificity and positive predictive 
value (97%, 91% and 96%, 87%, respectively) but 
low sensitivity (48% and 41%, respectively) to 
detect sepsis. The conclusion was procalcitonin 
>2.3 ng/ml or CRP >30 mg/l indicates a high 
likelihood for neonatal sepsis, and antibiotic 
therapy should be continued even in the presence of 
sterile cultures. However, it is not a readily 
available diagnostic assay in most institutions.
26 
 
Cell surface markers 
 
Neutrophil CD11b and CD64 appear to be 
promising markers for diagnosis of early and late 
onset infections. 
For culture-positive sepsis episodes, the CD64 
index had the highest area under the curve (0.852) 
of all hematological variables, with a sensitivity of 
80% and a specificity of 79%, with a cutoff value 
of 4.02. So, neutrophil CD64 is a highly sensitive 
marker for neonatal sepsis. Prospective studies 
incorporating CD64 into a sepsis scoring system 
are warranted.
27 
CD11b is a subunit of the b2 integrin adhesion 
molecule, normally expressed at a very low 
concentration on the surface of non-activated 
neutrophils. There is a 2–4 fold increase in 
neutrophil CD11b expression in infants with blood 
culture positive sepsis. The sensitivity and 
specificity of CD11b for diagnosing early onset 
neonatal sepsis are 96–100% and 81-100%, 
respectively. But in preterm infants with RDS, 
significant activation
  of circulating phagocytes 
occurs within 1 to 3 hours of the
  onset of 
mechanical ventilation, independent of surfactant 
administration,
  which indicates that mechanical 
ventilation may be the inducer
  of this systemic Tripathi et al / Neonatal sepsis: past, present and future 
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inflammatory response. Therefore, CD11b is not a 
good marker for neonatal sepsis
28. 
 
Granulocyte colony stimulating factor  
 
Granulocyte colony stimulating factor (GCSF), a 
mediator produced by bone marrow, facilitates 
proliferation and differentiation of neutrophils, and 
has been proposed to be a reliable infection marker 
for early diagnosis of neonatal sepsis. A 
concentration  ≥ 200 pg/ml has a high sensitivity 
(95%) and negative predictive value (99%) for 
predicting early onset neonatal bacterial and fungal 
infections.
29  
 
Cytokines 
 
As antigen specific immunity develops later e.g. at 
2 years of age in the case for encapsulated bacteria, 
neonates initially depend on natural (innate) 
immunity. This includes phagocytes (by 
monocytes, tissue macrophages, and neutrophils), 
natural killer cells, and humoral mediators (CRP, 
complements, and transplacentally acquired 
maternal antibodies). In response to antigens such 
as bacterial endotoxins, activated tissue 
macrophages produce tumor necrosis factor (TNF) 
and interleukin (IL). These proinflammatory 
cytokines stimulate endothelial cells to express 
receptors for intercellular adhesion molecule on 
white blood cells. This initiates the cytokine 
cascade towards increased production of IL6, IL8, 
and chemokines. Newborn infants display a higher 
percentage of IL6 and IL8 positive cells than do 
adults. There is sharp rise in IL6 concentration on 
exposure to bacterial products, which precedes the 
increase in CRP. Umbilical cord blood IL6 has 
consistently been shown to be a sensitive marker 
for diagnosing early onset neonatal sepsis at the 
onset of infection compared with other biochemical 
markers, including CRP, IL1ß, TNFα, and E-
selectin, but sensitivity is reduced at 24 and 48 
hours  because IL6 concentrations fall rapidly and 
become undetectable after 24 hours. The combined 
measurement of IL6 (early and sensitive) with CRP 
(late and specific) in the first 48 hours of presumed 
septic episodes improves the sensitivity compared 
with either marker alone.
30 Median values of IL-6 
(pg/ml) were higher in infants with sepsis vs. those 
with no sepsis on days 0 [40 vs. 13] (p = 0.03) and 
1 [24 vs. 9] (p < 0.001). IL-8 levels were not 
significantly different. IL-6 levels may be useful in 
the initiation as well as early termination of 
antibiotic therapy in late-onset neonatal sepsis.
31 
IL8 is a proinflammatory cytokine that is 
predominantly produced by monocytes, 
macrophages, and endothelial cells, with similar 
kinetics to IL6. IL8 is considered to be a highly 
accurate marker with sensitivities ranging from 
80% to 91% and specificities from 76% to 100%. A 
recent multicentric randomised controlled trial of 
1291 clinically stable infants with clinical signs or 
obstetric risk factors suggesting early onset 
neonatal sepsis revealed that the combination of 
IL8 >70 pg/ml and/or CRP >10 mg/l significantly 
reduced antibiotic therapy from 49.6% to 36.1% 
(p<0.0001) without missing infections; sensitivity 
was 80%, specificity 87%, positive predictive value 
68%, and negative predictive value 93%.
32 In the 
model of assessing concentration suggested by Ng 
PC et al., they obtained 100% sensitivity and 97% 
specificity of IL-10, IL-6 and RANTES for 
identifying infected preterm infants, who developed 
DIC. It would be particularly valuable to broaden 
the panel of studies by the chemokines helpful in 
diagnosing sepsis in adults such as GRO-α, MIP-1α 
or ENA-78.
33 
TNFα is a proinflammatory cytokine that 
stimulates IL6 production and has a broad spectrum 
of biological actions on several types of target cell, 
both immune and non-immune. Newborns 
developing early onset infection are born with 
higher TNFα concentrations than non-infected 
infants. 
Other markers studied over the last few years 
include adhesion molecules (intercellular adhesion 
molecule 1, vascular cell adhesion molecule 1, E-
selectin, L-selectin)
  and complement activation 
products (C3a-desArg, C3bBbP, sC5b-9),
   IL-
1alpha, IL-1beta, IL receptor antagonist (IL1ra)
  
which have been found to be significantly 
increased during sepsis, but require further 
evaluation for clinical application in the diagnosis 
of newborn infection.
 
It has been demonstrated that median IL-6 and 
TNF-α levels were significantly higher in groups 
with patients with a diagnosis of clinical sepsis than 
in controls. The optimal cut-off point was 32 pg /ml 
for IL-6 and 12 pg /ml for TNF-α. The combination 
of TNF-α and IL-6 provided a sensitivity of 98.5% 
and it is a highly sensitive marker of sepsis in the 
immediate postnatal period.
34 
In a recent study it was demonstrated that cytokines 
released in sepsis have an important role in 
stimulating Nucleated RBC (NRBC) production 
independent of hypoxia. In this study significantly 
elevated NRBC demonstrated in EOS (no EONS 
(n=49)) 1330 cells/ cmm (665-2630), EONS 
(n=19)3020 cells/cmm (1388-4558), p=0.011) 
along with significantly elevated IL-6 in EONS, but 
no increase in level of umbilical cortisol or 
erythropoietin. Increase NRBC count immediately 
after birth could be an interesting marker of EONS 
in absence of hypoxia and awaits further 
evaluation.
35 
 
Molecular genetics
36-39 
 
Polymerase chain reaction (PCR) analysis relies on 
the fact that the bacteria specific 16S rRNA gene is Tripathi et al / Neonatal sepsis: past, present and future 
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highly conserved in all bacterial genomes, is a 
useful method for identification of bacteria in 
clinical samples. Amplification targeting of this 
16S rRNA gene is a potentially valuable clinical 
tool in samples with low copy numbers of bacterial 
DNA, as this gene is present at 1 to more than 10 
copies in all bacterial genomes. The gene also has a 
number of divergent regions nested within it, so 
PCR can be targeted for species specific detection 
of bacteria in clinical samples. This technology has 
also been reported to be a very sensitive (100%) 
and rapid method for detecting potential pathogens 
in amniotic fluid commonly involved in the 
pathogenesis of preterm labour and adverse 
neonatal outcome.
36  
However, the performance of broad range PCR 
analysis at a level of high analytical sensitivity is 
complex and remains one of the most challenging 
PCR applications in the diagnostic laboratory. For 
example, as 16S rRNA gene amplification targets 
all bacterial species, small amounts of inherent 
residual DNA present in reagents may be co-
amplified, resulting in false positivity. Methods for 
the removal of potential background contamination 
include long wave UV light gamma irradiation 
DNAse, restriction endonuclease digestion, 
ultrafiltration, and low DNA polymerases. 
However, many of these methods result in a 
reduced sensitivity in detecting target DNA, with a 
detection limit range of 10
3–10
4 copies/ml, which is 
not ideal for diagnosing sepsis in clinical settings. 
It was found that a combination of pre-PCR culture 
with the use of AmpliTaq Low DNA achieves an 
acceptable level of sensitivity (5–50 copies/ml in a 
turnaround time of eight hours) for the real time 
amplification of bacteria in blood samples, without 
the need to remove any inherent DNA 
contamination. Detection by PCR does not yield 
the antimicrobial sensitivity pattern of the 
pathogen.  Early exclusion of bacterial infection 
could help to reduce overuse of antibiotics. It is 
predicted that eventually real time PCR combined 
with DNA Micro Array technology will allow not 
only identification of the organism but also the 
antimicrobial sensitivity pattern, which is so critical 
to clinical care.  
It has been revealed from an Indian study that PCR 
is useful and superior to blood culture for early 
diagnosis of sepsis in neonates with 100% 
sensitivity and 95.6% specificity, and once 
available in most tertiary centers can help in early 
and accurate diagnosis.
37  
 
Role of proteomics for diagnosis of neonatal 
infection
40, 41  
 
In a study, it was found significant alterations in 
levels of eight serum proteins in infected preterm 
neonates (specifically P- and E-selectins, 
interleukin 2, soluble receptor α, interleukin 18, 
neutrophil elastase, urokinase plasminogen 
activator and its cognate receptor, and C-reactive 
protein) were observed at statistically significant 
increased levels. 
40 
Molecular tools (16S-rRNA) demonstrate that the 
diversity of microbial agents of intra-amniotic 
infection exceeds what is suspected clinically or is 
documented by cultures. The resulting 
inflammatory process has the potential to damage 
the fetus in utero. Stepwise algorithms (mass 
restricted score) have been developed to extract 
proteomic profiles characteristic of amniotic fluid 
inflammation. The mass restricted score includes 
four proteomic biomarkers: defensin-2, defensin-1, 
S100A12, and S100A8 proteins. Other amniotic 
fluid biomarkers relevant for preterm birth are 
S100A9 and insulin-like growth factor-binding 
protein 1. S100A12 - ligand for the receptor of 
advanced glycation end products - has the strongest 
association with histological chorioamnionitis and 
funisitis. So the conclusion was - Presence of 
S100A12 and S100A8 in amniotic fluid is 
predictive of early-onset neonatal sepsis and poor 
neurodevelopmental outcome.
41 
 
MANAGEMENT
 
 
Supportive Treatment  
 
Attention should be given to basic supportive care 
in a sick child. The infant should be nursed in a 
thermoneutral environment taking care to avoid 
hypothermia and hyperthermia. Oxygen saturation 
should be maintained in the normal range and 
ventilation should be initiated as required. The 
infant should be regularly monitored for 
hypoglycemia/ hyperglycemia. Colloids and 
inotropes are used for maintaining normal blood 
pressure and tissue perfusion. Enteral feeds should 
be avoided till the baby is haemodynamically 
stable. Packed cells and fresh frozen plasma should 
be used appropriately for the management of 
anemia and bleeding diathesis.   
 
Antimicrobial Treatment  
 
The choice of antibiotic for an infant with 
suspected sepsis will depend upon the predominant 
pathogen and antibiotic sensitivity pattern of a 
given region. For the neonates in whom we suspect 
community acquired sepsis and in whom resistant 
strains are unlikely, the combination of ampicillin 
and gentamicin is advised for septicemia and 
pneumonia. Add third generation cephalosporin 
e.g. cefotaxime if meningitis is present in these 
cases. Cefotaxime, a broad spectrum cephalosporin 
should be used because of its reduced toxicity. 
Ceftriaxone is not commonly used because of 
potential of displacement of bilirubin from albumin 
and can cause hypoprothrombinemia and bleeding. Tripathi et al / Neonatal sepsis: past, present and future 
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When infection is hospital acquired and there is 
high probability of resistant strain, cefotaxime in 
combination with an aminoglycoside should be 
used for septicemia, pneumonia as well as 
meningitis. 3rd generation cephalosporins have 
very good CSF penetration and are traditionally 
thought to have excellent antimicrobial activity 
against gram-negative organisms. Hence they were 
considered to be a good choice for the treatment of 
nosocomial infections and meningitis. However, 
recent reports suggest that at least 60-70% of the 
gram-negative organisms are resistant to them. 
Moreover, routine use of these antibiotics might 
increase the risk of infections with extended 
spectrum beta-lactamase (ESBL) positive 
organisms. Therefore it is preferable to use 
antibiotics such as piperacillin-tazobactam or 
methicillin/vancomycin in units with high 
incidence of resistant strains. A combination of 
piperacillin-tazobactam with amikacin should be 
considered if pseudomonas sepsis is suspected. 
Penicillin resistant staphylococcus aureus should be 
treated with cloxacillin, nafcillin or methicillin. 
Addition of an aminoglycoside is useful in therapy 
against staphylococcus. Methicillin resistant 
staphylococcus aureus (MRSA) should be treated 
with a combination of ciprofloxacin or vancomycin 
with amikacin. Ciprofloxacin has excellent activity 
against gram-negative organisms also; however, it 
does not have good CSF penetration. It may be 
used for the treatment of resistant gram-negative 
bacteremia after excluding meningitis. For sepsis 
due to enterococcus, a combination of ampicillin 
and gentamicin is a good choice for initial therapy. 
Vancomycin should be used for the treatment of 
enterococcus resistant to the first line of therapy. 
Reserve antibiotics:  Newer antibiotics like 
aztreonam, meropenem and imipenem are also now 
available in the market. Aztreonam has excellent 
activity against gram-negative organisms while 
meropenem is effective against most bacterial 
pathogens except methicillin resistant 
staphylococcus aureus (MRSA) and enterococcus. 
Imipenem is generally avoided in neonates because 
of the reported increase in the incidence of seizures 
following its use. Empirical use of these antibiotics 
should be avoided; they should be reserved for 
situations where sensitivity of the isolated organism 
warrants its use. A simple approach for the 
management of sepsis is given in Figure 1. 
 
 
Figure 1: Suspected Neonatal Sepsis 
 
Duration of antibiotic therapy: 
•  Clinical sepsis (Based on clinical suspicion 
and/or sepsis screen positivity) -7-10 days 
•  Culture positive sepsis (not meningitis), UTI -
14 days  
•  Meningitis-2 weeks after sterilization of CSF 
culture or for a minimum of 2 weeks for gram 
positive meningitis and 3 weeks for gram 
negative meningitis, whichever is longer. 
•  Bone and joint infection-4-6 weeks 
 
Adjunctive therapy 
 
Intravenous Immune Globulin (IVIG): According 
to Cochrane database systemic review there is 
insufficient evidence to support the routine 
administration of IVIG preparations investigated to 
date to prevent mortality in infants with suspected 
or subsequently proved neonatal infection.
42 
Immunotherapy used as an adjuvant for the 
prevention and treatment of neonatal sepsis holds 
promise. However clinical trials specifically 
designed toward the neonatal population and 
appropriately powered to detect treatment 
differences are necessary prior to universal 
recommendation of these therapies in the nursery.
43 
In a recent paper, the authors have reviewed 
immunotherapies that modulate the immune system 
of the neonate, including intravenous 
immunoglobulins and myeloid haematopoietic Tripathi et al / Neonatal sepsis: past, present and future 
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growth factors. Future studies should focus on 
investigating other abnormalities of neonatal host 
defence and/or combined immunotherapy 
approaches in an attempt to circumvent the 
immaturity of host defense and potentially reduce 
both the incidence and severity of neonatal sepsis.
44 
Granulocyte colony stimulating factor (G-CSF 
45-
47: Carr and colleagues reported a randomized trial 
(PROGRAMS) of GM-CSF for the prevention of 
sepsis in small for gestational age preterm 
neonates. This increased the neutrophil count, but 
had no effect on the primary end point of sepsis 
free survival to 14 days from trial entry.
45  
According to the Cochrane database systemic 
review there is currently insufficient evidence to 
support the introduction of either G-CSF or 
Granulocyte monocyte colony stimulating factor 
(GM-CSF) into neonatal practice, either as 
treatment of established systemic infection to 
reduce resulting mortality, or as prophylaxis to 
prevent systemic infection in high risk neonates. 
The limited data suggesting that G-CSF treatment 
may reduce mortality when systemic infection is 
accompanied by severe neutropenia should be 
investigated further in adequately powered trials 
which recruit sufficient infants infected with 
organisms associated with a significant mortality 
risk.
46 
Exchange transfusion: Exchange transfusion in 
neonatal sepsis has not been extensively studied. It 
may be used with caution in neonatal sepsis 
associated with neutropenia, sclerema, earliest 
evidence of disseminated intravascular coagulation 
and metabolic acidosis (pH <7.2).
48  
Pentoxifylline: Pentoxifylline is a methylxanthine 
that has been postulated to improve outcomes in 
sepsis through modulating the activity of the 
reticuloendothelial system and decreasing the 
neutrophil activation that contributes to acute tissue 
injury. Large scale clinical trials have not yet been 
performed.
49 
 
ACCURACY OF DIAGNOSTIC TESTS 
 
The accuracy of diagnostic tests or combinations of 
tests for early Onset neonatal sepsis has been 
summarized in Table 2. 
 
Table 2 Accuracy of Diagnostic Tests or Combinations of Tests for Early Onset Neonatal Sepsis 
 
Diagnostic test with cutoff  Sensitivity 
(%) 
Specificity 
(%) 
PPV  
(%) 
NPV 
(%) 
Antenatal 
Amniotic TNF  41 pg/ml
50  82 79 47  95 
PCR for genomic DNA in amniotic fluid
36 100  100  100  100 
Postnatal 
CRP
 (5 mg/dl)
 21 95      98 
CRP (high cutoff 30mg/dl)
23 41  91  87   
Procalcitonin (high cutoff 2.3ng/ml )
 23 48  97  96   
CD64 index plus ANC  95  57  63  93 
CD64 index
 (4.02)
 24 70  62  59  73 
IL-6
 (32 pg/ml)
28 98.5       
GCSF  200 pg/m
26  95 73 40  99 
Umbilical cord IL6   87–90  93  93  93–100 
IL6 &
 IL10 & RANTES
30 100  97     
IL6 (32 pg/ml) and TNF- α(12pg/ml) 98.5      
IL8 (not good marker)  -  -  -  - 
Real time PCR
47 100  100  100  100 
 
CONCLUSION 
 
Clinical diagnosis of sepsis in new born infants is 
not easy because symptoms and signs are non-
specific. There is no laboratory test with 100% 
specificity and sensitivity, and hence, the search 
has continued for a reliable test. Blood culture has 
been the gold standard for confirmation of 
diagnosis but the results of the test are available 
only after 48-72 hours. The neonates with "risk 
factors" for neonatal sepsis are thus treated with 
broad-spectrum antibiotics and require prolonged 
hospitalization. Although many putative markers 
(acute phase reactants, cell surface markers, and 
cytokines) are reported in various clinical research 
settings, most are not available to the routine 
diagnostic laboratory. Furthermore, the greatest 
predictability usually results from a combination of 
assays. Ultimately, application of the various tools 
of molecular biology, such as PCR with Micro Tripathi et al / Neonatal sepsis: past, present and future 
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Array chip technology, should allow rapid 
identification of potential pathogens together with 
antimicrobial resistance markers. 
 
REFERENCES 
 
1.  Bang AT, Bang RA, Baitule SB, et al. Effect 
of home-based neonatal care and management 
of sepsis on neonatal mortality: field trial in 
rural India. Lancet 1999 Dec;354(9194):1955-
61. 
2.  Stoll BJ. The global impact of neonatal 
infection.  Clin Perinatol. 1997 Mar;24(1):1-
21. 
3.  Report of the National Neonatal Perinatal 
Database. Report 2002-2003. NNPD Network. 
2005 Jan; 
http://www.newbornwhocc.org/pdf/nnpd_repo
rt_2002-03.PDF 
4.  Sankar MJ, Agarwal A, Deorari AK, et al. 
Sepsis in the newborn. Indian J Pediatr. 2008 
Mar;75(3):261-6. 
5.  Sudaram V, Kumar P, Dutta S, et al. Blood 
culture confirmed bacterial sepsis in neonates 
in a north Indian tertiary care center: changes 
over the last decade. Jpn J Infect Dis. 2009 
Jan;62(1):46-50. 
6.  Kaftan H, Kinney JS. Early onset neonatal 
bacterial infections. Semin Perinatol. 1998 
Feb;22(1):15-24. 
7.  Belady PH, Farkouh LJ, Gibbs RS. Intra-
amniotic infections and premature rupture of 
membranes.  Clin Perinatol. 1997 
Mar;24(1):43-57. 
8.  Aggarwal R, Sarkar N, Deorari AK, et al. 
Sepsis in the newborn. Indian J Pediatr. 2001 
Dec;68(12):1143-7. 
9.  Baltimore RS. Neonatal nosocomial infection. 
Semin Perinatol 1998 Feb;22(1):25-32. 
10.  Wolach B. Neonatal sepsis: pathogenesis and 
supportive therapy. Semin Perinatol. 1997 
Feb;21(1):28-38. 
11.  Griffin MP, Lake DE, O'Shea TM, et al. Heart 
rate characteristics and clinical signs in 
neonatal sepsis. Pediatr Res. 2007 
Feb;61(2):222-7. 
12.  Kovatchev BP, Farhy LS, Cao H, et al. Sample 
asymmetry of heart rate characteristics with 
application to neonatal sepsis and systemic 
inflammatory response syndrome. Pediatr Res. 
2003 Dec;54(6):892-8. 
13.  Garcia FG, Nager AL. Jaundice as an early 
diagnostic sign of urinary tract infection in 
infancy. Pediatrics. 2002 May;109(5):846-51. 
14.  De Felice C, Flori ML, Pellegrino M, et al. 
Predictive value of skin color for illness 
severity in the high risk newborn. Pediatr Res. 
2002 Jan;51:100-5. 
15.  Polinski C. The value of the white blood cell 
count and differential count in the prediction of 
neonatal sepsis. Neonatal Netw. 1996 
Oct;15(7):13-23. 
16.  Da Silva O, Ohlossan A, Kenyon C. Accuracy 
of leucocyte indices and C- reactive protein for 
diagnosis of neonatal sepsis: a critical review. 
Pediatr Infect Dis J. 1995;14:362-6. 
17.  Manroe BL, Weinberg AG, Rosenfeld CR, et 
al. The neonatal blood count in health and 
disease. I. Refernce values for neutrophilic 
cells. J Pediatr. 1979 Jul;95(1):89-98. 
18.  Mouzinho A, Rosenfeld CR, Sanchez PJ, et al. 
Revised reference ranges for circulating 
neutrophils in very-low-birth-weight neonates. 
Pediatrics. 1994 Jul;94(1):76-82. 
19.  Rosenberg AE, Ahmed AS, Saha SK, et al. 
Nosocomial sepsis risk score for preterm 
infants in low-resource settings. J Trop 
Pediatr. 2010 Apr;56(2):82-9. 
20.  Sundaram V, Dutta S, Ahluwalia J, et al. Score 
for neonatal acute physiology II predicts 
mortality and persistent organ dysfunction in 
neonates with severe septicemia. Indian 
Pediatr. 2009 Sep;46(9):775-80. 
21.  Paul V, Agrawal R. Neonatal sepsis. In: NNF 
Manual of Neonatal Care. 1
st ed, Prism Books 
Pvt. Ltd, Bangalore, 121-34. 
22.  Richard A, Polin, Elvira P, et al. Bacterial 
sepsis and meningitis. William T, Roberta A, 
Christine A Avery’s Disease of the Newborn, 
8th ed 2005;551-77. 
23.  Chiesa C, Pellegrini G, Panero A. C-reactive 
protein, interleukin-6, and procalcitonin in the 
immediate postnatal period: influence of 
illness severity, risk status, antenatal and 
perinatal complications, and infection. Clin 
Chem. 2003 Jan;49(1):60-8. 
24.  Khassawneh M, Hayajneh WA, Kofahi H, et 
al. Diagnostic markers for neonatal sepsis: 
comparing C-reactive protein, interleukin-6 
and immunoglobulin M. Scand J Immunol. 
2007 Feb;65(2):171-5. 
25.  Cetinkaya M, Ozkan H, Köksal N, et al. 
Comparison of serum amyloid A 
concentrations with those of C-reactive protein 
and procalcitonin in diagnosis and follow-up 
of neonatal sepsis in premature infants. J 
Perinatol. 2009 Mar;29(3):225-31. 
26.  Turner D, Hammerman C, Rudensky B, et al. 
The role of procalcitonin as a predictor of 
nosocomial sepsis in preterm infants. Acta 
Paediatr. 2006 Dec;95(12):1571-6. 
27.  Bhandari V, Wang C, Rinder C, et al. 
Hematologic profile of sepsis in neonates: 
neutrophil CD64 as a diagnostic marker. 
Pediatrics. 2008 Jan;121(1):129-34. 
28.  Turunen R, Nupponen I, Siitonen S,  et al. 
Onset of mechanical ventilation is associated 
with rapid activation of circulating phagocytes 
in preterm infants. Pediatrics. 2006 
Feb;117(2):448-54. Tripathi et al / Neonatal sepsis: past, present and future 
54 
Copyrighted © by Dr. Arun Kumar Agnihotri. All right reserved 
29.  Kennon C, Overturf G, Bessman S, et al. 
Granulocyte colony-stimulating factor as a 
marker for bacterial infection in neonates. J 
Pediatr. 1996 Jan;128:765-9. 
30.  Mehr S, Doyle LW. Cytokines as markers of 
bacterial sepsis in newborn infants: a review. 
Pediatr Infect Dis J. 2000 Sep;19(9):879-87. 
31.  Gonzalez BE, Mercado CK, Johnson L, et al. 
Early markers of late-onset sepsis in premature 
neonates: clinical, hematological and cytokine 
profile. J Perinat Med. 2003;31(1):60-8. 
32.  Franz AR, Bauer K, Schalk A. Measurement 
of interleukin 8 in combination with C-reactive 
protein reduced unnecessary antibiotic therapy 
in newborn infants: a multicenter, randomized, 
controlled trial. Pediatrics 2004 Jul;114:1–8. 
33.  Ng PC, Li K, Leung TF, et al. Early prediction 
of sepsis-induced disseminated intravascular 
coagulation with interleukin-10, interleukin-6, 
and RANTES in preterm infants. Clin Chem. 
2006 Jan;52(6):1181-9. 
34.  Silveria RC, Procianoy RS. Evaluation of 
interleukin-6, tumor necrosis factor-alpha and 
interleukin-1beta for early diagnosis of 
neonatal sepsis. Acta Paediatr. 1999 
Jan;88(6):647-50. 
35.  Dulay AT, Buhimschi IA, Zhao G, et al. 
Nucleated red blood cells are a direct response 
to mediators of inflammation in newborns with 
early-onset neonatal sepsis. Am J Obstet 
Gynecol. 2008 Apr;198(4):426.e1- e9. 
36.  Maiwald M. Broad-range PCR for the 
detection and identification of bacteria. 
Molecular microbiology: diagnostic principles 
and practice. 2nd ed. Washington DC: 
American Society of Microbiology, 2004;379-
90. 
37.  Yadav AK, Wilson CG, Prasad PL, et al. 
Polymerase chain reaction in rapid diagnosis of 
neonatal sepsis.  Indian Pediatr. 2005 
Jul;42(7):681-5. 
38.  Frayha HH, Kalloghlian, A. Gram-specific 
quantitative polymerase chain reaction for 
diagnosis of neonatal sepsis: implications for 
clinical practice. Crit Care Med. 2009 
Aug;37(8):2487-8. 
39.  Straka M, Dela Cruz W, Blackmon C. Rapid 
detection of group B streptococcus and 
Escherichia coli in amniotic fluid using real-
time fluorescent PCR. Infect Dis Obstet 
Gynecol. 2004 Sep-Dec;12(3-4):109-14. 
40.  Kingsmore SF, Kennedy N, Halliday HL, et al. 
Identification of diagnostic biomarkers for 
Infection in premature neonates. Mol Cell 
Proteomics. 2008 Oct;7(10):1863-75. 
41.  Buhimschi CS, Bhandari V, Han YW, et al. 
Using proteomics in perinatal and neonatal 
sepsis: hopes and challenges for the future. 
Curr Opin Infect Dis. 2009 Jun;22(3):235-43. 
42.  Ohlsson A, Lacy J. Intravenous 
immunoglobulin for suspected or subsequently 
proven infection in neonates. Cochrane 
Database Syst Rev. 2004;(1):CD0011239. 
43.  Cohen-Wolkowiez M, Benjamin DK Jr, 
Capparelli E. Immunotherapy in neonatal 
sepsis: advances in treatment and prophylaxis. 
Curr Opin Pediatr. 2009 Apr; 21(2):177-81. 
44.  Shaw CK, Thapalial A, Shaw P, et al 
Intravenous immunoglobulins and 
haematopoietic growth factors in the 
prevention and treatment of neonatal sepsis: 
ground reality or glorified myths? Int J Clin 
Pract. 2007 Mar;61(3):482-7. 
45.  Carr R, Brocklehurst P, Dore C, et al. 
Granulocyte-macrophage colony stimulating 
factor administered as prophylaxis for 
reduction of sepsis in extremely preterm, small 
for gestational age neonates (the PROGRAMS 
trial): a single-blind, multicentre, randomised 
controlled trial. Lancet. 2009 Jan; 
373(9659):226-33. 
46.  Carr R, Modi N, Dore C. G-CSF and GM-CSF 
for treating or preventing neonatal infection. 
Cochrane database syst Rev. 
2003;(3):CD003066. 
47.  Gathwala G,   Bala H. Colony stimulating 
factors as adjunctive therapy in neonatal 
sepsis. Indian J Pediatr. 2006 May;73(5):393-
4. 
48.  Mathur NB. Neonatal sepsis. Indian Pediatr. 
1996;33:663-76. 
49.  Hasque E, Mohan P. Pentoxiphylline for 
neonatal sepsis. Cochrane database syst rev. 
2003;(4):CD004205. 
50.  Park KH, Yoon BH, Shim SS. Amniotic fluid 
tumor necrosis factor-alpha is a marker for the 
prediction of early-onset neonatal sepsis in 
preterm labor. Gynecol Obstet Invest. 
2004;58(2):84-90. 
 